Trial intelligence / Profile preview

Strontium ranelate vs alendronate on bone microarchitecture in postmenopausal osteoporosis

2006-002732-22Phase 3Completed

Sponsor
Servier
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postmenopausal osteoporosis and fragility fracture comparing Strontium ranelate arm with Alendronate arm (2 arms). Started Oct 2006; status: completed.

02

Drugs

strontium ranelatealendronate
03

Conditions

postmenopausal osteoporosisfragility fracture

Beyond the preview

Go deeper on 2006-002732-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002732-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call